title: Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization.
abstract: Tumor-associated macrophages are known to influence cancer progression by modulation of immune function, angiogenesis, and cell metastasis, however, little is known about the chemokine signaling networks that regulate this process. Utilizing CT26 colon cancer cells and RAW 264.7 macrophages as a model cellular system, we demonstrate that treatment of CT26 cells with RAW 264.7 conditioned medium induces cell migration, invasion and metastasis. Inflammatory gene microarray analysis indicated CT26-stimulated RAW 264.7 macrophages upregulate SDF-1alpha and VEGF, and that these cytokines contribute to CT26 migration in vitro. RAW 264.7 macrophages also showed a robust chemotactic response towards CT26-derived chemokines. In particular, microarray analysis and functional testing revealed CSF-1 as the major chemoattractant for RAW 264.7 macrophages. Interestingly, in the chick CAM model of cancer progression, RAW 264.7 macrophages localized specifically to the tumor periphery where they were found to increase CT26 tumor growth, microvascular density, vascular disruption, and lung metastasis, suggesting these cells home to actively invading areas of the tumor, but not the hypoxic core of the tumor mass. In support of these findings, hypoxic conditions down regulated CSF-1 production in several tumor cell lines and decreased RAW 264.7 macrophage migration in vitro. Together our findings suggest a model where normoxic tumor cells release CSF-1 to recruit macrophages to the tumor periphery where they secrete motility and angiogenic factors that facilitate tumor cell invasion and metastasis.
authors.affiliation: Department of Pathology and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America.
authors.forename: Chad E
authors.initials: CE
authors.lastname: Green
authors.forename: Tiffany
authors.initials: T
authors.lastname: Liu
authors.forename: Valerie
authors.initials: V
authors.lastname: Montel
authors.forename: Gene
authors.initials: G
authors.lastname: Hsiao
authors.forename: Robin D
authors.initials: RD
authors.lastname: Lester
authors.forename: Shankar
authors.initials: S
authors.lastname: Subramaniam
authors.forename: Steven L
authors.initials: SL
authors.lastname: Gonias
authors.forename: Richard L
authors.initials: RL
authors.lastname: Klemke
mesh_terms: D000818:Animals; D002460:Cell Line; D002465:Cell Movement; D002630:Chemotactic Factors / Q000378:metabolism*; D002642:Chick Embryo; D017077:Culture Media, Conditioned; D020869:Gene Expression Profiling; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D009389:Neovascularization, Pathologic; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D015398:Signal Transduction
chemical_list: D002630:Chemotactic Factors; D017077:Culture Media, Conditioned
references.citation: J Cell Biol. 2007 Jul 30;178(3):425-36
references.pmid: 17664334
references.citation: Mol Cancer Res. 2007 Jan;5(1):21-33
references.pmid: 17259344
references.citation: Br J Cancer. 1999 Feb;79(5-6):991-5
references.pmid: 10070902
references.citation: Carcinogenesis. 2004 Aug;25(8):1543-9
references.pmid: 15044327
references.citation: Am J Pathol. 2000 Aug;157(2):411-21
references.pmid: 10934146
references.citation: J Cell Biol. 2000 Apr 3;149(1):223-36
references.pmid: 10747099
references.citation: J Cell Biol. 2004 Oct 25;167(2):223-9
references.pmid: 15504909
references.citation: Am J Pathol. 1994 Oct;145(4):856-67
references.pmid: 7943176
references.citation: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W627-32
references.pmid: 15980550
references.citation: Bioinformatics. 2004 Nov 22;20(17):3108-27
references.pmid: 15217816
references.citation: J Exp Med. 2001 Mar 19;193(6):727-40
references.pmid: 11257139
references.citation: Cancer Res. 2005 Jul 1;65(13):5578-87
references.pmid: 15994930
references.citation: Annu Rev Pathol. 2006;1:119-50
references.pmid: 18039110
references.citation: Lancet. 1993 Jul 17;342(8864):148-9
references.pmid: 8101258
references.citation: Nature. 2005 Jul 28;436(7050):518-24
references.pmid: 16049480
references.citation: Nat Rev Cancer. 2003 May;3(5):362-74
references.pmid: 12724734
references.citation: Am J Physiol Cell Physiol. 2007 Mar;292(3):C987-95
references.pmid: 16943240
references.citation: J Pathol. 2002 Feb;196(2):204-12
references.pmid: 11793372
references.citation: Cell. 2006 Jan 27;124(2):263-6
references.pmid: 16439202
references.citation: Nat Rev Cancer. 2006 Jul;6(7):506-20
references.pmid: 16794634
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17406-11
references.pmid: 17954920
references.citation: J Leukoc Biol. 1995 May;57(5):747-51
references.pmid: 7539028
references.citation: Cancer Lett. 2008 Aug 28;267(2):204-15
references.pmid: 18448242
references.citation: Cancer Res. 2005 Jun 15;65(12):5278-83
references.pmid: 15958574
references.citation: Nat Rev Genet. 2006 Jan;7(1):55-65
references.pmid: 16369572
references.citation: Cancer Res. 2006 Jan 15;66(2):605-12
references.pmid: 16423985
references.citation: Trends Immunol. 2002 Nov;23(11):549-55
references.pmid: 12401408
references.citation: J Cell Biol. 1997 Apr 21;137(2):481-92
references.pmid: 9128257
references.citation: J Immunol. 2006 Apr 15;176(8):5023-32
references.pmid: 16585599
references.citation: Histochem Cell Biol. 2008 Dec;130(6):1119-30
references.pmid: 19005674
references.citation: J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):177-89
references.pmid: 12463738
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6
references.pmid: 11134512
references.citation: Am J Pathol. 2005 May;166(5):1565-79
references.pmid: 15855655
references.citation: Blood. 2004 Oct 15;104(8):2224-34
references.pmid: 15231578
references.citation: Mol Oncol. 2007 Dec;1(3):288-302
references.pmid: 18509509
references.citation: Anticancer Res. 2004 Sep-Oct;24(5C):3335-42
references.pmid: 15515429
references.citation: Nat Rev Cancer. 2004 Jan;4(1):71-8
references.pmid: 14708027
references.citation: Cancer Res. 2004 Oct 1;64(19):7022-9
references.pmid: 15466195
references.citation: Int J Cancer. 2005 Dec 10;117(5):701-8
references.pmid: 16106399
references.citation: J Cell Biol. 1998 Feb 23;140(4):961-72
references.pmid: 9472046
references.citation: J Pathol. 2000 Oct;192(2):150-8
references.pmid: 11004690
references.citation: Br J Cancer. 1994 Aug;70(2):289-92
references.pmid: 7519867